Pinnacle Wealth Management Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.19M Buy
4,719
+3
+0.1% +$645 0.55% 42
2026
Q1
$1.03M Buy
4,716
+180
+4% +$39.9K 0.5% 45
2025
Q4
$1.04M Sell
4,536
-35
-0.8% -$7.97K 0.52% 45
2025
Q3
$1.06M Buy
4,571
+3
+0.1% +$611 0.54% 42
2025
Q2
$848K Buy
4,568
+2
+0% +$372 0.49% 41
2025
Q1
$957K Buy
4,566
+2
+0% +$389 0.67% 36
2024
Q4
$811K Buy
4,564
+2
+0% +$368 0.51% 41
2024
Q3
$901K Sell
4,562
-2,205
-33% -$412K 0.57% 39
2024
Q2
$1.16M Buy
6,767
+2
+0% +$331 0.79% 32
2024
Q1
$1.23M Buy
6,765
+92
+1% +$15.9K 0.92% 29
2023
Q4
$1.03M Hold
6,673
0.85% 34
2023
Q3
$995K Hold
6,673
0.91% 32
2023
Q2
$899K Sell
6,673
-920
-12% -$135K 0.79% 32
2023
Q1
$1.21M Sell
7,593
-100
-1% -$15.3K 1.05% 27
2022
Q4
$1.24M Hold
7,693
1.1% 28
2022
Q3
$1.03M Hold
7,693
0.91% 28
2022
Q2
$1.18M Sell
7,693
-200
-3% -$30.6K 0.99% 29
2022
Q1
$1.28M Sell
7,893
-115
-1% -$16.7K 0.96% 29
2021
Q4
$1.08M Hold
8,008
0.8% 35
2021
Q3
$864K Sell
8,008
-280
-3% -$32K 0.65% 40
2021
Q2
$934K Buy
+8,288
New +$933K 0.68% 37

Other funds holding ABBV

Pinnacle Wealth Management Group's ABBV Position: Q2 2026 in Review

Pinnacle Wealth Management Group increased its AbbVie (ABBV) stake by 0.06% in Q2 2026, buying an estimated $645 and bringing the position to 4,719 shares worth $1.19M. The position accounts for 0.55% of the portfolio, ranked #42.

Pinnacle Wealth Management Group first reported a position in ABBV in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.28M in Q1 2022. 926 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Pinnacle Wealth Management Group held 4,719 shares of AbbVie worth $1.19M as of Q2 2026.
  • Pinnacle Wealth Management Group bought 3 AbbVie shares in Q2 2026, an estimated $645.
  • AbbVie made up 0.55% of Pinnacle Wealth Management Group's portfolio in Q2 2026, its #42 holding.
  • Pinnacle Wealth Management Group first reported a position in AbbVie in Q2 2021 and has held it in 21 quarters since.
  • Pinnacle Wealth Management Group's AbbVie position peaked at $1.28M in Q1 2022.
  • 926 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Pinnacle Wealth Management Group's 13F filing for Q2 2026, filed 15 Jul 2026.